Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. November 2025 09:49 ET | Quelle: Research and Markets

Direct Oral Anticoagulants (DOACs) Device Market Report 2025-2029 and 2034: Market Set for Strong Growth Driven by Cardiovascular Disease Surge and Personalized Care Adoption

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Direct Oral Anticoagulants (DOACs) Device Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The direct oral...
24. Februar 2025 11:26 ET | Quelle: Research and Markets

Direct Oral Anticoagulants (DOACs) Market Projected to Reach $49.88 Billion by 2030 - Surge in Cardiovascular Disease Prevalence and Drug Innovations Fuels Growth

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
24. Januar 2024 10:32 ET | Quelle: Research and Markets

Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
25. April 2012 13:00 ET | Quelle: American Heart Association

Stroke Risk High When Anti-Clotting Drugs Stopped

Study Highlights: Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped. The risks are similar...
08. September 2011 18:26 ET | Quelle: American Heart Association

AHA Perspective on FDA Committee Decision on Rivaroxaban

DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...